|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2007-12-10
|
|
pubmed:abstractText |
Invasive aspergillosis (IA) has a poor prognosis in immunocompromised patients. Combinations of drugs that act on different targets are expected to improve the clinical efficacy of separate compounds.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
2007 American Cancer Society
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2740-6
|
|
pubmed:meshHeading |
pubmed-meshheading:17941026-Adolescent,
pubmed-meshheading:17941026-Adult,
pubmed-meshheading:17941026-Aged,
pubmed-meshheading:17941026-Amphotericin B,
pubmed-meshheading:17941026-Aspergillosis,
pubmed-meshheading:17941026-Drug Therapy, Combination,
pubmed-meshheading:17941026-Echinocandins,
pubmed-meshheading:17941026-Female,
pubmed-meshheading:17941026-Hematologic Neoplasms,
pubmed-meshheading:17941026-Humans,
pubmed-meshheading:17941026-Male,
pubmed-meshheading:17941026-Middle Aged,
pubmed-meshheading:17941026-Pilot Projects,
pubmed-meshheading:17941026-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial).
|
|
pubmed:affiliation |
Hematology Department, Dijon University Hospital Center, Dijon, France. denis.caillot@chu-dijon.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
